SimFinder: A Unique Topology- based Approach to Similarity Searching 1.

Slides:



Advertisements
Similar presentations
JKlustor clustering chemical libraries presented by … maintained by Miklós Vargyas Last update: 25 March 2010.
Advertisements

Leveraging ChemAxon Cheminformatics in an Integrated Drug Discovery and Development Platform Zhenbin Li, Paul Starbard, Jim Gregory, Donald Chen, Paul.
Chemaxon's chemo-informatics toolkit integration into the Affectis Data Management System Database Automated Data Integration - Example: IC50 Data generated.
UGM 2007 Miklós Vargyas*, Judit Vaskó-Szedlár Whats new in LibraryMCS.
1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
Classifying the WADA 2005 Prohibited List Using the CDK Fingerprint Ed Cannon & John Mitchell www-mitchell.ch.cam.ac.uk/
Analysis of High-Throughput Screening Data C371 Fall 2004.
Modern Tools for Drug Discovery NIMBUS Biotechnology Modern Tools for Drug Discovery
A Multiobjective Approach to Combinatorial Library Design Val Gillet University of Sheffield, UK.
PharmaMiner: Geometric Mining of Pharmacophores 1.
Library Design for Leadlike Compounds: A Historical Perspective Tudor I. Oprea EST Lead Informatics.
GraphSig: Mining Significant Substructures in Compound Libraries 1.
Establishing a Successful Virtual Screening Process Stephen Pickett Roche Discovery Welwyn.
Chemistry & Life Science Data. What do we do? Is is new (claimed)? Novelty Can I get, buy, make it? Availability Is it useful? Validation.
Design of Small Molecule Drugs Targeted to RNA RNA Ontology Group May
Active Learning Strategies for Drug Screening 1. Introduction At the intersection of drug discovery and experimental design, active learning algorithms.
Active Learning Strategies for Compound Screening Megon Walker 1 and Simon Kasif 1,2 1 Bioinformatics Program, Boston University 2 Department of Biomedical.
1 BrainWave Biosolutions Limited Accelerating Life Science Research through Technology.
Methodology Conceptual Database Design
Data Mining – Intro.
Conformetrix A new dimension in drug discovery Conformetrix © All rights reserved. Conformetrix Ltd Background technology and its application to.
MDL Keys Revisited Joseph L. Durant, Burton A. Leland, Douglas R. Henry and James G. Nourse MDL Information Systems.
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
1 The Discovery Informatics Framework Pat Rougeau President and CEO MDL Information Systems, Inc. Delivering the Integration Promise American Chemical.
Combinatorial Chemistry and Library Design
Graph Indexing Techniques Seoul National University IDB Lab. Kisung Kim
Topological Summaries: Using Graphs for Chemical Searching and Mining Graphs are a flexible & unifying model Scalable similarity searches through novel.
Similarity Methods C371 Fall 2004.
Leiden University. The university to discover. Enhancing Search Space Diversity in Multi-Objective Evolutionary Drug Molecule Design using Niching 1. Leiden.
VAMOS Visualization of Accessible Molecular Space A new compound filtering and selection interface Spotfire User Conference - Europe - May , 2003.
Fusing database rankings in similarity-based virtual screening Peter Willett, University of Sheffield.
Genomics Research Institute University of Cincinnati Compound Library Wm. L. Seibel January 10, 2007.
New approaches to elucidating Structure Activity Relationships Chris Petersen Technical Manager, Informatics.
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Function first: a powerful approach to post-genomic drug discovery Stephen F. Betz, Susan M. Baxter and Jacquelyn S. Fetrow GeneFormatics Presented by.
ChEMBL– Open Access Database For Drug Discovery By – Udghosh Singh M.S.(Pharm), 3 rd Sem Pharmacoinformatics.
CONCLUSION & FUTURE WORK Given a new user with an information gathering task consisting of document IDs and respective term vectors, this can be compared.
Summarizing the Content of Large Traces to Facilitate the Understanding of the Behaviour of a Software System Abdelwahab Hamou-Lhadj Timothy Lethbridge.
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
ChemBank Building a Public Web Resource Using Daycart Erik Brauner Head of Chemical and Biological Computing Harvard Institute of Chemistry and Cell Biology.
Data Mining – Intro. Course Overview Spatial Databases Temporal and Spatio-Temporal Databases Multimedia Databases Data Mining.
SAR vs QSAR or “is QSAR different from SAR”
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Klaus Gubernator, Craig James, e Molecules Inc. ACS 232nd National Meeting Division of Chemical Information San Francisco, September 14, 2006 Chemical.
Selecting Diverse Sets of Compounds C371 Fall 2004.
Computer-aided drug discovery (CADD)/design methods have played a major role in the development of therapeutically important small molecules for several.
PharmaMiner: Geometric Mining of Pharmacophores 1.
Catalyst TM What is Catalyst TM ? Structural databases Designing structural databases Generating conformational models Building multi-conformer databases.
Design of a Compound Screening Collection Gavin Harper Cheminformatics, Stevenage.
Use of Machine Learning in Chemoinformatics
Identification of structurally diverse Growth Hormone Secretagogue (GHS) agonists by virtual screening and structure-activity relationship analysis of.
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
High-Throughput Screening Core Facility at CU-Boulder Wei Wang
3D Fragment Consortium Dr Andy Morley Project Manager.
Reaxys – The Highlights. Slide 2 What is Reaxys? A brand new workflow solution for research chemists and scientists from related disciplines An extensive.
Structure-Based Computational Database Screening, In Vitro Assay, and NMR Assessment of Compounds that Target TAR RNA Kenneth E Lind, Zhihua Du, Koh Fujinaga,
Molecular Modeling in Drug Discovery: an Overview
Indiana University School of Indiana University ECCR Summary Infrastructure: Cheminformatics web service infrastructure made available as a community resource.
Nehad A. El Sayed, Amal A. H. Eissa, Reem K. Arafa and Ghada F. El Masry* Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University.
Introduction to PubChem BioAssay
of novel 1,2,3-triazolyl appended L-ascorbic acid derivatives
Immunological Library
Global Health Chemical Diversity Library
Can Drug Discovery Research be Done At An Undergraduate Institution?
Selcia Fragment Library
Ligand-Based Structural Hypotheses for Virtual Screening
Virtual Screening.
ASSIGNMENT 10 Use the UP and DOWN tags as provided and query the LINCS. These are the KRAS-DEP (UP) and KRAS-IND (DOWN) gene signatures from Singh et al.
Megon Walker Bioinformatics Program Boston University
CNS BBB Library ChemDiv Inc..
Presentation transcript:

SimFinder: A Unique Topology- based Approach to Similarity Searching 1

SimFinder Topology-based similarity search Flexibility – Parameterized similarity measure – User-defined functional group abstractions Scalability using index structure – One-to-many comparisons at a time between query compound and database compounds Alternative techniques rely on one-to-one comparisons 2

Applications of SimFinder Better diversity analysis of databases – Topology reveals unique insights Functional group abstractions – User-directed User can define graph attributes (e.g., types of covalent & non-covalent bonds). Ligand-protein interactions can be defined & queried. 3

4 FlexibilityIntuitiveness Scalability SimFInder Only technology offering flexibility, intuitive searches, and scalability Unity & Daylight fingerprints, MACCS ECFP, FCFP MCS Key Benefits

Retrospective Validation Briem & Lessel compound library 957 compound subset MDL Drug Data Report (MDDR) classified by biological activity Query result enriched in the biological activity of the query compound.

Serotonin Re-uptake Inhibition SimFinder finds more active compounds

Platelet Activating Factor Antagonist SimFinder finds more active compounds

Thromboxane A2 Antagonist SimFinder finds more active compounds

BACE-1 & BBB Permeability Studies ChemBridge library filtered to remove reactive functional groups + Acelot Blood Brain Barrier permeability filters Acelot SimFinder queries on curated library with known BACE-1 inhibitors Compounds reviewed for medicinal chemistry considerations, ordered, and %-inhibition determined via in vitro BACE-1 assay.

BACE-1 Study Query Structures o Statines Little overlap between GraphSim and Fingerprint similarity search results. Leads are o low MW o fragment-like o tractable with respect to Med. Chem. Non-statins (hydroxyethylene isostere) in hit list. o SimFinder search yields unique compounds and not "more-of-the-same".

Summary of Retrospective Studies Better than fingerprints via retrospective studies. Complementary and unique query methods yield complementary and unique drug leads. o novel view of sample bank o new structural class of drug lead o topological approach yields unique structural classes of drug-leads for a given target class. o Chemical space explored is complementary to fingerprints or other non-toploogy based methods

References Huahai He; Ambuj K. Singh; Closure-tree: An Index Structure for Graph Queries. Proceedings of the 22nd International Conference on Data Engineering (ICDE), April, 2006, pp DOI : /ICDE DOI : /ICDE Hans Briem and Uta F Lessel, Perspect. Drug Discov. Dec (20),